-
Product Insights
NewCharcot-Marie-Tooth Disease Type I – Drugs In Development, 2024
Empower your strategies with our Charcot-Marie-Tooth Disease Type I – Drugs In Development, 2024 report and make more profitable business decisions. Charcot-Marie-Tooth disease, a group of hereditary sensory and motor neuropathies affecting peripheral nerves, leads to progressive damage connecting the brain and spinal cord to muscles and sensory cells. Manifesting in adolescence or adulthood, it causes sensation alteration, muscle wasting, and varying physical disabilities. Initial symptoms involve muscle atrophy in the feet, often accompanied by foot abnormalities, and difficulties in flexing...
-
Product Insights
NewCharcot-Marie-Tooth Disease – Drugs In Development, 2024
Empower your strategies with our Charcot-Marie-Tooth Disease – Drugs In Development, 2024 report and make more profitable business decisions. Charcot-Marie-Tooth disease (CMT) is a term for a group of inherited genetic disorders that affect the peripheral nerves, which connect the brain and spinal cord to the muscles and sensory organs. CMT causes progressive weakness, muscle wasting, and loss of sensation in the feet, legs, hands, and arms. It can also cause foot deformities such as high arches or flat feet. CMT...
-
Product Insights
NewCharcot-Marie-Tooth Disease Type I A – Drugs In Development, 2024
Empower your strategies with our Charcot-Marie-Tooth Disease Type I A – Drugs In Development, 2024 report and make more profitable business decisions. Charcot–Marie–Tooth disease type 1A (CMT1A), the most frequent form of CMT, is caused by a 1.5 Mb duplication on the short arm of chromosome 17. CMT1 is characterized by muscle weakness and atrophy, which can lead to repeated ankle sprains, and changes in sensation (paresthesia), which can cause clumsiness. Symptoms of this form of CMT usually start in childhood...
-
Product Insights
NewCharcot-Marie-Tooth Disease Type II – Drugs In Development, 2024
Empower your strategies with our Charcot-Marie-Tooth Disease Type II – Drugs In Development, 2024 report and make more profitable business decisions. Charcot–Marie–Tooth disease (CMT) is a hereditary motor and sensory neuropathy of the peripheral nervous system characterized by progressive loss of muscle tissue and touch sensation across various parts of the body. Symptoms include Loss of touch sensation in the feet, ankles, and legs as well as in the hands, wrists, and arms occurs with various types of the disease. CMT...